FDA Import Refusal 799-0032262-9/11/2 — Sanofi-Aventis Deutschland GmbH
The FDA refused shipment 799-0032262-9/11/2 from Sanofi-Aventis Deutschland GmbH (Germany) on Jul 27, 2022. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 27, 2022
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75